Nvidia's stock has had a killer run. Why it's still Morgan Stanley's top AI-chip pick.
By Emily Bary
Nvidia's $2.2 trillion market cap, once seen as 'unfathomable,' could head even higher, according to Morgan Stanley
Nvidia Corp. has a nearly $2.2 trillion market capitalization, which would have been thought of as "unfathomable a few quarters ago," according to a Morgan Stanley analyst.
Yet even after Nvidia's (NVDA) blockbuster stock performance last year and its strong start to 2024 - it's up 75% on a year-to-date basis - Morgan Stanley's Joseph Moore says the name is still his preferred way to play the artificial-intelligence chip boom. The analyst upped his price target on the overweight-rated stock to $1,000, from $795, late Tuesday.
There are several reasons behind Moore's view, he noted in his latest report. For one, the company's "product execution - and potentially aggressive pricing - will pressure alternatives."
Read: Nvidia and these other chip stocks named top plays into earnings season
Nvidia recently showed off its new Blackwell chip lineup and surprised some on Wall Street with its talk of pricing. While the numbers aren't exact, the company indicated that it was pricing the chips aggressively in a bid to grow the market and make them more accessible.
Additionally, Moore said that there's been a shortage of rack space, which he sees as beneficial to Nvidia in winning market share.
See also: SoundHound plans to sell stock after big rally, and its shares are sliding
"Through most of 2023, there were shortages of GPUs, and the tighter allocation environment was a factor driving purchasing behavior," he wrote. "Cloud customers viewed alternatives - custom silicon or merchant - as a project, to alleviate dependency on Nvidia and differentiate offerings from competitors' offerings."
But now the bottlenecks don't seem to be about graphics processing units, but rather about rack space. "Faced with limited slots for AI processors, we are seeing some of the appetite for alternatives taking a back seat to the highest [return-on-investment] processor, which continues to be Nvidia," Moore said.
Rack-scale products could help Nvidia boost its revenue potential, he added.
Additionally, Moore flagged that he likes Nvidia's stock more than names within the company's supply chain. He said that "upside that is already being felt in markets, such as [high-bandwidth memory] or optical, points to future upside for Nvidia."
Don't miss: Nvidia's stock enters a correction. Here's where the other Magnificent Seven stocks stand.
Plus, it's not as if the Nvidia wannabes haven't seen monster stock runs of their own, either. The stock multiples for Advanced Micro Devices Inc. (AMD) and Marvell Technology Inc. (MRVL) have hit highs, "as stocks have gone up while overall numbers have come down." Shares of Micron Technology Inc. (MU) and Applied Materials Inc. (AMAT), which also stand to benefit from AI-chip spending, have also seen nice runs.
-Emily Bary
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
04-10-24 1611ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters